Novavax Inc (NVAX)

R&D to Revenue

124.68%

Quarterly · Period ending:

NVAX logo

NVAX R&D to Revenue

Latest reported124.68%
NVAX Quarterly R&D/Revenue (800.00% → 124.68%)
High-resolution chart · PNG

NVAX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
48.2945%
52.1949%
346.5923%
790.2703%
359.3537%
214.6479%
171.4286%
1,100%
200%
500%
650%
450%
700%
300%
300%
700%
800%
600%
0%
800%
900%
800%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.